The global Pulmonary Valved Conduit market size was valued at US$ 100 million in 2024 and is forecast to a readjusted size of USD 142 million by 2031 with a CAGR of 5.1% during review period.
Pulmonary Valved Conduits are medical devices used to replace or bypass a diseased or dysfunctional pulmonary valve in patients with congenital heart defects or other heart conditions. They consist of a conduit (tube) that incorporates a valve to allow for proper blood flow from the heart to the lungs.
麻豆原创 Overview:
The pulmonary valved conduit market is driven by the increasing prevalence of congenital heart diseases and advancements in valve technologies. These conduits are essential for treating patients with pulmonary valve disorders, especially those with congenital abnormalities or who have undergone previous surgeries requiring valve replacement.
麻豆原创 Drivers:
Increasing incidence of congenital heart diseases and the growing number of pediatric heart surgeries.
Advances in biomaterial technologies, allowing for more durable and compatible conduits.
麻豆原创 Opportunities:
Growth in demand for tissue-engineered valves and conduits that offer improved longevity and better integration with patient tissues.
Emerging markets, especially in Asia-Pacific and Latin America, where cardiovascular disease rates are increasing.
麻豆原创 Limitations:
High costs of advanced pulmonary valved conduits, particularly for younger patients requiring repeated surgeries as they grow.
Limited availability of donor tissue for tissue-engineered options.
This report is a detailed and comprehensive analysis for global Pulmonary Valved Conduit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pulmonary Valved Conduit market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Pulmonary Valved Conduit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Pulmonary Valved Conduit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (US$/Unit), 2020-2031
Global Pulmonary Valved Conduit market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pulmonary Valved Conduit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pulmonary Valved Conduit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Xeltis, Edwards Lifesciences, Labcor, Balance Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Pulmonary Valved Conduit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Biological Materials
Polymer Synthetic Materials
麻豆原创 segment by Application
Hospital
Clinic
Major players covered
Medtronic
Xeltis
Edwards Lifesciences
Labcor
Balance Medical
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Valved Conduit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Valved Conduit, with price, sales quantity, revenue, and global market share of Pulmonary Valved Conduit from 2020 to 2025.
Chapter 3, the Pulmonary Valved Conduit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Valved Conduit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pulmonary Valved Conduit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Valved Conduit.
Chapter 14 and 15, to describe Pulmonary Valved Conduit sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Pulmonary Valved Conduit Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Biological Materials
1.3.3 Polymer Synthetic Materials
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Pulmonary Valved Conduit Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Pulmonary Valved Conduit 麻豆原创 Size & Forecast
1.5.1 Global Pulmonary Valved Conduit Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pulmonary Valved Conduit Sales Quantity (2020-2031)
1.5.3 Global Pulmonary Valved Conduit Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Pulmonary Valved Conduit Product and Services
2.1.4 Medtronic Pulmonary Valved Conduit Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Medtronic Recent Developments/Updates
2.2 Xeltis
2.2.1 Xeltis Details
2.2.2 Xeltis Major Business
2.2.3 Xeltis Pulmonary Valved Conduit Product and Services
2.2.4 Xeltis Pulmonary Valved Conduit Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Xeltis Recent Developments/Updates
2.3 Edwards Lifesciences
2.3.1 Edwards Lifesciences Details
2.3.2 Edwards Lifesciences Major Business
2.3.3 Edwards Lifesciences Pulmonary Valved Conduit Product and Services
2.3.4 Edwards Lifesciences Pulmonary Valved Conduit Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Edwards Lifesciences Recent Developments/Updates
2.4 Labcor
2.4.1 Labcor Details
2.4.2 Labcor Major Business
2.4.3 Labcor Pulmonary Valved Conduit Product and Services
2.4.4 Labcor Pulmonary Valved Conduit Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Labcor Recent Developments/Updates
2.5 Balance Medical
2.5.1 Balance Medical Details
2.5.2 Balance Medical Major Business
2.5.3 Balance Medical Pulmonary Valved Conduit Product and Services
2.5.4 Balance Medical Pulmonary Valved Conduit Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Balance Medical Recent Developments/Updates
3 Competitive Environment: Pulmonary Valved Conduit by Manufacturer
3.1 Global Pulmonary Valved Conduit Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pulmonary Valved Conduit Revenue by Manufacturer (2020-2025)
3.3 Global Pulmonary Valved Conduit Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Pulmonary Valved Conduit by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Pulmonary Valved Conduit Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Pulmonary Valved Conduit Manufacturer 麻豆原创 Share in 2024
3.5 Pulmonary Valved Conduit 麻豆原创: Overall Company Footprint Analysis
3.5.1 Pulmonary Valved Conduit 麻豆原创: Region Footprint
3.5.2 Pulmonary Valved Conduit 麻豆原创: Company Product Type Footprint
3.5.3 Pulmonary Valved Conduit 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pulmonary Valved Conduit 麻豆原创 Size by Region
4.1.1 Global Pulmonary Valved Conduit Sales Quantity by Region (2020-2031)
4.1.2 Global Pulmonary Valved Conduit Consumption Value by Region (2020-2031)
4.1.3 Global Pulmonary Valved Conduit Average Price by Region (2020-2031)
4.2 North America Pulmonary Valved Conduit Consumption Value (2020-2031)
4.3 Europe Pulmonary Valved Conduit Consumption Value (2020-2031)
4.4 Asia-Pacific Pulmonary Valved Conduit Consumption Value (2020-2031)
4.5 South America Pulmonary Valved Conduit Consumption Value (2020-2031)
4.6 Middle East & Africa Pulmonary Valved Conduit Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Pulmonary Valved Conduit Sales Quantity by Type (2020-2031)
5.2 Global Pulmonary Valved Conduit Consumption Value by Type (2020-2031)
5.3 Global Pulmonary Valved Conduit Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Pulmonary Valved Conduit Sales Quantity by Application (2020-2031)
6.2 Global Pulmonary Valved Conduit Consumption Value by Application (2020-2031)
6.3 Global Pulmonary Valved Conduit Average Price by Application (2020-2031)
7 North America
7.1 North America Pulmonary Valved Conduit Sales Quantity by Type (2020-2031)
7.2 North America Pulmonary Valved Conduit Sales Quantity by Application (2020-2031)
7.3 North America Pulmonary Valved Conduit 麻豆原创 Size by Country
7.3.1 North America Pulmonary Valved Conduit Sales Quantity by Country (2020-2031)
7.3.2 North America Pulmonary Valved Conduit Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Pulmonary Valved Conduit Sales Quantity by Type (2020-2031)
8.2 Europe Pulmonary Valved Conduit Sales Quantity by Application (2020-2031)
8.3 Europe Pulmonary Valved Conduit 麻豆原创 Size by Country
8.3.1 Europe Pulmonary Valved Conduit Sales Quantity by Country (2020-2031)
8.3.2 Europe Pulmonary Valved Conduit Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Pulmonary Valved Conduit Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pulmonary Valved Conduit Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pulmonary Valved Conduit 麻豆原创 Size by Region
9.3.1 Asia-Pacific Pulmonary Valved Conduit Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pulmonary Valved Conduit Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Pulmonary Valved Conduit Sales Quantity by Type (2020-2031)
10.2 South America Pulmonary Valved Conduit Sales Quantity by Application (2020-2031)
10.3 South America Pulmonary Valved Conduit 麻豆原创 Size by Country
10.3.1 South America Pulmonary Valved Conduit Sales Quantity by Country (2020-2031)
10.3.2 South America Pulmonary Valved Conduit Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Pulmonary Valved Conduit Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pulmonary Valved Conduit Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pulmonary Valved Conduit 麻豆原创 Size by Country
11.3.1 Middle East & Africa Pulmonary Valved Conduit Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pulmonary Valved Conduit Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Pulmonary Valved Conduit 麻豆原创 Drivers
12.2 Pulmonary Valved Conduit 麻豆原创 Restraints
12.3 Pulmonary Valved Conduit Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Pulmonary Valved Conduit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pulmonary Valved Conduit
13.3 Pulmonary Valved Conduit Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pulmonary Valved Conduit Typical Distributors
14.3 Pulmonary Valved Conduit Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Medtronic
Xeltis
Edwards Lifesciences
Labcor
Balance Medical
听
听
*If Applicable.
